Jump to content

Recommended Posts

Here is the weekly clip report:
“Dr. Larner on Integrating Radiation Therapy With Immune Checkpoint Blockade in NSCLC”
Diagnostic Imaging
“Low Dose CT Lung Cancer Screening Program Findings Similar to National Trial”
Targeted Oncology
“Immunotherapy and Chemotherapy Combos Are the New Standard of Care for NSCLC, Says Konduri”
“Dr. Jotte on the Optimal Frequency of Lung Cancer Screening”
Targeted Oncology
“Immunotherapy Combinations Are Changing the Frontline Treatment of Patients With NSCLC”
Cancer Therapy Advisor
“Heterogeneity of Drug Resistance in EGFR-Mutant Non-Small Cell Lung Cancer”
Speciality Pharmacy Times
First Checkpoint Inhibitor for Previously Treated Patients with SCLC Approved by FDA https://www.specialtypharmacytimes.com/news/first-checkpoint-inhibitor-for-previously-treated-patients-with-sclc-approved-by-fda

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...

Important Information

By using this site, you agree to our Terms of Use.